Symmetry Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,525
| Closed | -$425K | – | 150 |
|
|
2024
Q2 | $425K | Sell |
5,525
-541
| -9% | -$41.6K | 0.02% | 322 |
|
|
2024
Q1 | $415K | Hold |
6,066
| – | – | 0.03% | 345 |
|
|
2023
Q4 | $341K | Sell |
6,066
-2,077
| -26% | -$117K | 0.02% | 363 |
|
|
2023
Q3 | $430K | Sell |
8,143
-606
| -7% | -$32K | 0.02% | 344 |
|
|
2023
Q2 | $473K | Sell |
8,749
-1,597
| -15% | -$86.3K | 0.03% | 354 |
|
|
2023
Q1 | $518K | Hold |
10,346
| – | – | 0.03% | 314 |
|
|
2022
Q4 | $479K | Hold |
10,346
| – | – | 0.03% | 344 |
|
|
2022
Q3 | $401K | Hold |
10,346
| – | – | 0.03% | 358 |
|
|
2022
Q2 | $386K | Hold |
10,346
| – | – | 0.03% | 381 |
|
|
2022
Q1 | $458K | Hold |
10,346
| – | – | 0.03% | 380 |
|
|
2021
Q4 | $439K | Hold |
10,346
| – | – | 0.03% | 431 |
|
|
2021
Q3 | $439K | Hold |
10,346
| – | – | 0.03% | 458 |
|
|
2021
Q2 | $442K | Hold |
10,346
| – | – | 0.03% | 472 |
|
|
2021
Q1 | $400K | Sell |
10,346
-216
| -2% | -$8.35K | 0.03% | 479 |
|
|
2020
Q4 | $380K | Sell |
10,562
-2,927
| -22% | -$105K | 0.03% | 459 |
|
|
2020
Q3 | $515K | Buy |
+13,489
| New | +$515K | 0.04% | 312 |
|
|
2019
Q4 | – | Sell |
-5,826
| Closed | -$237K | – | 332 |
|
|
2019
Q3 | $237K | Sell |
5,826
-683
| -10% | -$27.8K | 0.05% | 292 |
|
|
2019
Q2 | $280K | Sell |
6,509
-9,936
| -60% | -$427K | 0.06% | 260 |
|
|
2019
Q1 | $631K | Buy |
16,445
+8,855
| +117% | +$340K | 0.11% | 122 |
|
|
2018
Q4 | $268K | Buy |
+7,590
| New | +$268K | 0.07% | 205 |
|